[HTML][HTML] The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction
V Crisóstomo, C Baéz-Diaz, V Blanco-Blázquez… - Scientific Reports, 2021 - nature.com
The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction
V Crisóstomo, C Baéz-Diaz… - Scientific …, 2021 - pubmed.ncbi.nlm.nih.gov
The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
[HTML][HTML] The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction
V Crisóstomo, C Baéz-Diaz, V Blanco-Blázquez… - Scientific …, 2021 - ncbi.nlm.nih.gov
The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction.
V Crisóstomo, C Baéz-Diaz… - Scientific …, 2021 - search.ebscohost.com
The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction
V Crisóstomo, C Baéz-Diaz… - Scientific …, 2021 - ui.adsabs.harvard.edu
The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction.
V Crisóstomo, C Baéz-Diaz, V Blanco-Blázquez… - Scientific …, 2021 - europepmc.org
The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …